Ela Markovsky
Affiliations: | Tel Aviv University, Tel Aviv-Yafo, Tel Aviv District, Israel |
Area:
drug delivery, cancerGoogle:
"Ela Markovsky"Mean distance: 106866
BETA: Related publications
See more...
Publications
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
Haimovitz-Friedman A, Humm J, Deasy JO, et al. (2019) Abstract 3735: An anti-tumor immune response is evoked by partial-volume single dose radiation Cancer Research |
Markovsky E, Budhu S, Samstein RM, et al. (2018) An Anti-Tumor Immune Response is Evoked By Partial-Volume Single Dose Radiation in Two Murine Models. International Journal of Radiation Oncology, Biology, Physics |
Markovsky E, de Stanchina E, Itzkowitz A, et al. (2018) Phosphorylation state of Ser in α-tubulin is a toggle switch that controls proliferating human breast tumors. Cellular Signalling. 52: 74-82 |
Wang F, Li H, Markovsky E, et al. (2018) Pazopanib radio-sensitization of human sarcoma tumors. Oncotarget. 9: 9311-9324 |
Vossen LI, Markovsky E, Eldar-Boock A, et al. (2018) PEGylated dendritic polyglycerol conjugate targeting NCAM-expressing neuroblastoma: Limitations and challenges. Nanomedicine : Nanotechnology, Biology, and Medicine. 14: 1169-1179 |
Markovsky E, Vax E, Ben-Shushan D, et al. (2017) Wilms Tumor NCAM-Expressing Cancer Stem Cells as Potential Therapeutic Target for Polymeric Nanomedicine. Molecular Cancer Therapeutics. 16: 2462-2472 |
Markovsky E, Eldar-Boock A, Ben-Shushan D, et al. (2017) Targeting NCAM-expressing neuroblastoma with polymeric precision nanomedicine. Journal of Controlled Release : Official Journal of the Controlled Release Society. 249: 162-172 |
Samstein R, Markovsky E, Li H, et al. (2017) Partial Tumor Irradiation in a Murine Model is Sufficient for Tumor Control via Activation of an Antitumor Immune Response International Journal of Radiation Oncology*Biology*Physics. 99: E616-E617 |
Baabur-Cohen H, Vossen L, Krüger HR, et al. (2016) In vivo comparative study of distinct polymeric architectures bearing a combination of paclitaxel and doxorubicin at a synergistic ratio. Journal of Controlled Release : Official Journal of the Controlled Release Society |
Markovsky E, Baabur-Cohen H, Satchi-Fainaro R. (2014) Anticancer polymeric nanomedicine bearing synergistic drug combination is superior to a mixture of individually-conjugated drugs. Journal of Controlled Release : Official Journal of the Controlled Release Society. 187: 145-57 |